Predictive Oncology Inc. (POAI)

Market Cap	4.18M
Revenue (ttm)	1.96M
Net Income (ttm)	-14.78M
Shares Out	4.10M
EPS (ttm)	-3.65
PE Ratio	n/a
Forward PE	n/a
Dividend	n/a
Ex-Dividend Date	n/a

Volume	42,014
Open	1.030
Previous Close	1.030
Day's Range	1.000 - 1.052
52-Week Range	0.894 - 7.120
Beta	1.33
Analysts	n/a
Price Target	n/a
Earnings Date	Aug 8, 2024

About POAI

Predictive Oncology Inc., a knowledge and science-driven company, applies artificial intelligence (AI) to support the discovery and development of optimal cancer therapies. It operates through three segments: Pittsburgh, Birmingham, and Eagan. The Pittsburgh segment provides services that include the application of AI using its proprietary biobank of approximately 150,000 tumor samples and creates proprietary 3D culture models used in drug development. The Birmingham segment offers contract services and research focused on solubility improvemen...

• Industry: Medical Instruments & Supplies
• Sector: Healthcare
• Founded: 2002
• Employees: 34
• Stock Exchange: NASDAQ
• Ticker Symbol: POAI

Financial Performance

In 2023, POAI's revenue was $1.78 million, an increase of 18.24% compared to the previous year's $1.51 million. Losses were -$13.98 million, -45.67% less than in 2022.